APA (7th ed.) Citation

Gabanti, E., Bruno, F., Lilleri, D., Fornara, C., Zelini, P., Cane, I., . . . Gerna, G. (2014). Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Gabanti, Elisa, et al. Human Cytomegalovirus (HCMV)-specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-organ Transplant Recipients. Public Library of Science (PLoS), 2014.

MLA (8th ed.) Citation

Gabanti, Elisa, et al. Human Cytomegalovirus (HCMV)-specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-organ Transplant Recipients. Public Library of Science (PLoS), 2014.